The PhytoPharma Consulting LLC (PCR) has won a $3 million federal grant to conduct an FDA-approved study of the effects on the brain of e (nicotine) vapor exposure.
The $2.5 million grant was awarded in April 2016, and the study is scheduled to begin later this year, the company said in a statement.
PCRI is a small, California-based consulting firm that specializes in conducting research on the effects, benefits, and safety of medications, medical devices, and pharmaceutical products.
It has been a leader in the field of neuroprotective compounds, such as e-cigarettes, since it started its efforts in the late 1990s, PCRI said.
“This is a big win for PCRI, which has been on the forefront of neuroprotection research for more than 25 years,” said Dr. John T. Tye, president of PCRI and president of the National Institutes of Health.
“PCRI’s work in this area is vital to the future of the brain, and this new grant supports our efforts to help inform our patients, patients, and their families as well as provide a resource for future researchers in this space.”
The research, conducted by the Center for Biomedical Informatics at the University of California, Berkeley, will be conducted by Dr. Rishi Kumar, PCR’s chief scientific officer and a professor of neuroscience at UC Berkeley.
Dr. Tylor R. Haines, PCri’s chief scientist and a former neurosurgeon, will serve as chief investigator.
PCR said it expects the results of the study to be published in the early 2020s.
Kumar and Hain and Dr. Raja Krishnan, a professor at UC-Berkeley and a member of PCR, will also serve as lead authors.
In addition to the study, PCP is also funding an additional $2 million grant for the work of researchers at the National Institute of Neurological Disorders and Stroke (NINDS), according to the statement.
The study is part of a larger effort that is being conducted by researchers at NINDS to study the effects e-cigs have on the brains of people with neurological diseases.
PCPI and NINDF have been collaborating in a large number of studies since 2015, according to PCRI.
In September, PCPI announced a $1.4 million grant from the NIH for a project that aims to examine e-cig vapor as a potential tool to combat neurological diseases, according the statement, and has also been working on e-Cigarettes to treat chronic pain.
In May, PCA signed a partnership with a company called VapeRus, which provides e-juice delivery systems.
In a statement, PCIA said the study was the first of its kind, and that it hoped to see the results published within the next year.
The group is working to produce a product that would deliver nicotine to the brain via a system called a “vape bank,” PCIA CEO Peter Siegel said in the statement at the time.
PCI’s work has also focused on the use of nicotine as a medication for Parkinson’s disease, diabetes, and a number of other conditions.
The research group’s most recent report focused on how e-smokers experience nicotine dependence and how it might relate to nicotine dependence, according PCRI’s statement.
For example, the study looked at how nicotine withdrawal affects smokers and nonsmokers, as well how nicotine might affect brain structure, function, and activity in those who use e-vapor products, according its statement.
“We are thrilled that this study will help to inform our industry about the benefits of ejuice products and to inform people who are considering taking e-liquid for the first time about the risks associated with using e-products as medications,” said PCRI president and CEO Dr. Joseph R. T. Biederman in a news release.
“While we can’t yet prove that e-smoking causes cancer, we are confident that ejuices and other nicotine products can be an effective way to prevent, treat, and even reverse cancer,” Dr. Bierman added.
PCIA has been working with several leading e-commerce companies, including Amazon, Ebay, and eBay, to promote e-nicotine as a way to help smokers quit smoking, the statement said.
The e-Juice Association, an e-medical and e-tech advocacy group, praised PCRI for the funding.
“There are hundreds of millions of people in the U.S. who use electronic cigarettes and are concerned that they could become addicted to nicotine, a substance that is known to be extremely toxic to the human body,” said Steve Hauslohner, president and chief executive officer of the e-